Myra Muramoto
Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Smoking Cessation | 30 | 2021 | 376 | 4.390 |
Why?
| Tobacco Use Cessation | 9 | 2017 | 21 | 3.430 |
Why?
| Complementary Therapies | 7 | 2017 | 72 | 2.730 |
Why?
| Tobacco Use Disorder | 12 | 2021 | 236 | 2.630 |
Why?
| Massage | 6 | 2021 | 42 | 2.090 |
Why?
| Smoking Prevention | 11 | 2021 | 157 | 2.030 |
Why?
| Smoking | 20 | 2021 | 1392 | 1.850 |
Why?
| Health Personnel | 9 | 2019 | 574 | 1.740 |
Why?
| Chiropractic | 4 | 2017 | 6 | 1.640 |
Why?
| Acupuncture | 2 | 2015 | 2 | 1.010 |
Why?
| Acupuncture Therapy | 5 | 2017 | 18 | 1.000 |
Why?
| Physical Therapy Specialty | 2 | 2015 | 34 | 0.960 |
Why?
| Smokers | 2 | 2021 | 129 | 0.840 |
Why?
| Curriculum | 5 | 2015 | 843 | 0.810 |
Why?
| Education, Distance | 2 | 2021 | 38 | 0.770 |
Why?
| Health Promotion | 6 | 2016 | 686 | 0.720 |
Why?
| Motivation | 6 | 2017 | 498 | 0.700 |
Why?
| Community Health Workers | 2 | 2011 | 45 | 0.680 |
Why?
| Secondary Prevention | 1 | 2021 | 222 | 0.670 |
Why?
| Behavior Therapy | 1 | 2021 | 227 | 0.640 |
Why?
| Nicotine | 7 | 2021 | 266 | 0.630 |
Why?
| Arizona | 7 | 2019 | 67 | 0.620 |
Why?
| Leadership | 1 | 2021 | 295 | 0.610 |
Why?
| Family Practice | 3 | 2021 | 427 | 0.600 |
Why?
| Bupropion | 4 | 2016 | 39 | 0.590 |
Why?
| Schools, Medical | 2 | 2015 | 122 | 0.550 |
Why?
| Teaching Materials | 1 | 2016 | 25 | 0.550 |
Why?
| Education, Continuing | 2 | 2016 | 39 | 0.540 |
Why?
| Education, Medical, Undergraduate | 2 | 2015 | 169 | 0.530 |
Why?
| Health Communication | 1 | 2016 | 41 | 0.520 |
Why?
| Substance-Related Disorders | 2 | 2021 | 946 | 0.500 |
Why?
| Delivery of Health Care | 3 | 2021 | 835 | 0.500 |
Why?
| Self Efficacy | 3 | 2014 | 355 | 0.490 |
Why?
| Patients | 1 | 2016 | 162 | 0.490 |
Why?
| Professional Practice | 1 | 2015 | 62 | 0.480 |
Why?
| Skin Neoplasms | 1 | 2021 | 758 | 0.460 |
Why?
| Developing Countries | 3 | 2015 | 236 | 0.430 |
Why?
| Teaching | 1 | 2014 | 221 | 0.400 |
Why?
| Health Knowledge, Attitudes, Practice | 4 | 2014 | 1184 | 0.390 |
Why?
| Humans | 53 | 2021 | 115042 | 0.390 |
Why?
| Program Development | 2 | 2019 | 346 | 0.370 |
Why?
| Health Education | 3 | 2010 | 323 | 0.370 |
Why?
| Indians, North American | 1 | 2015 | 570 | 0.350 |
Why?
| Social Support | 4 | 2010 | 528 | 0.350 |
Why?
| Female | 34 | 2021 | 59613 | 0.350 |
Why?
| Adult | 24 | 2017 | 30656 | 0.350 |
Why?
| Alcohol Drinking | 1 | 2015 | 655 | 0.340 |
Why?
| Male | 29 | 2021 | 55731 | 0.330 |
Why?
| Inservice Training | 1 | 2010 | 107 | 0.330 |
Why?
| Decision Making | 2 | 2021 | 782 | 0.320 |
Why?
| Couples Therapy | 2 | 2006 | 13 | 0.320 |
Why?
| Breast Feeding | 2 | 2008 | 367 | 0.310 |
Why?
| Law Enforcement | 1 | 2008 | 37 | 0.300 |
Why?
| Amphetamine-Related Disorders | 1 | 2008 | 28 | 0.300 |
Why?
| Drug and Narcotic Control | 1 | 2008 | 29 | 0.300 |
Why?
| Occupational Health | 1 | 2010 | 164 | 0.290 |
Why?
| Methamphetamine | 1 | 2008 | 51 | 0.290 |
Why?
| Faculty, Medical | 2 | 2009 | 232 | 0.290 |
Why?
| Education | 2 | 2014 | 95 | 0.290 |
Why?
| Referral and Consultation | 3 | 2010 | 633 | 0.290 |
Why?
| Professional-Patient Relations | 1 | 2008 | 140 | 0.280 |
Why?
| Risk Reduction Behavior | 1 | 2008 | 201 | 0.280 |
Why?
| Central Nervous System Stimulants | 1 | 2008 | 139 | 0.270 |
Why?
| Manipulation, Chiropractic | 2 | 2016 | 3 | 0.270 |
Why?
| Postpartum Period | 1 | 2008 | 278 | 0.260 |
Why?
| United States | 9 | 2021 | 12226 | 0.260 |
Why?
| Middle Aged | 14 | 2021 | 26827 | 0.260 |
Why?
| Coronary Disease | 1 | 2006 | 347 | 0.230 |
Why?
| Young Adult | 8 | 2017 | 10498 | 0.220 |
Why?
| Interviews as Topic | 2 | 2016 | 584 | 0.220 |
Why?
| Feedback | 2 | 2021 | 146 | 0.220 |
Why?
| Mothers | 1 | 2008 | 652 | 0.210 |
Why?
| Focus Groups | 3 | 2016 | 385 | 0.210 |
Why?
| Program Evaluation | 3 | 2019 | 825 | 0.210 |
Why?
| Diagnosis, Dual (Psychiatry) | 1 | 2021 | 35 | 0.200 |
Why?
| Surveys and Questionnaires | 4 | 2019 | 4631 | 0.200 |
Why?
| Nicotinic Agonists | 1 | 2003 | 100 | 0.200 |
Why?
| Adolescent | 14 | 2017 | 17864 | 0.190 |
Why?
| Indonesia | 4 | 2015 | 18 | 0.190 |
Why?
| Substance Withdrawal Syndrome | 2 | 2003 | 159 | 0.190 |
Why?
| Medication Adherence | 2 | 2016 | 537 | 0.190 |
Why?
| Patient Education as Topic | 4 | 2010 | 682 | 0.190 |
Why?
| Longitudinal Studies | 4 | 2010 | 2389 | 0.190 |
Why?
| Health Behavior | 2 | 2021 | 704 | 0.190 |
Why?
| Qualitative Research | 3 | 2011 | 935 | 0.180 |
Why?
| Community Health Services | 2 | 2010 | 211 | 0.180 |
Why?
| Certification | 1 | 2000 | 89 | 0.170 |
Why?
| Personal Satisfaction | 1 | 2021 | 182 | 0.170 |
Why?
| Feasibility Studies | 2 | 2021 | 746 | 0.170 |
Why?
| Health Surveys | 4 | 2015 | 443 | 0.170 |
Why?
| Forecasting | 1 | 2021 | 332 | 0.170 |
Why?
| Psychotherapy, Group | 1 | 2019 | 61 | 0.160 |
Why?
| Reagent Strips | 1 | 1999 | 4 | 0.160 |
Why?
| Research Design | 2 | 2015 | 930 | 0.160 |
Why?
| Guidelines as Topic | 1 | 2000 | 245 | 0.160 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2006 | 928 | 0.160 |
Why?
| Substance Abuse Detection | 1 | 1999 | 62 | 0.150 |
Why?
| Tobacco Products | 2 | 2014 | 101 | 0.150 |
Why?
| Recurrence | 1 | 2021 | 941 | 0.150 |
Why?
| Aged | 7 | 2016 | 19119 | 0.150 |
Why?
| Contraceptives, Oral, Hormonal | 1 | 2017 | 23 | 0.150 |
Why?
| Evidence-Based Medicine | 2 | 2003 | 676 | 0.150 |
Why?
| Computer Simulation | 1 | 2021 | 880 | 0.140 |
Why?
| Evaluation Studies as Topic | 1 | 2017 | 169 | 0.140 |
Why?
| Psychiatry | 1 | 2019 | 155 | 0.140 |
Why?
| Hospitals | 1 | 2021 | 582 | 0.140 |
Why?
| Contraception Behavior | 1 | 2017 | 80 | 0.140 |
Why?
| Cross-Sectional Studies | 8 | 2017 | 4411 | 0.140 |
Why?
| Follow-Up Studies | 4 | 2011 | 4420 | 0.140 |
Why?
| Alcohol Abstinence | 1 | 2015 | 10 | 0.130 |
Why?
| Cell Phone | 1 | 2016 | 77 | 0.130 |
Why?
| Mental Health Services | 1 | 2019 | 321 | 0.130 |
Why?
| Binge Drinking | 1 | 2015 | 32 | 0.130 |
Why?
| Mobile Applications | 1 | 2016 | 140 | 0.120 |
Why?
| Health Priorities | 2 | 2015 | 34 | 0.120 |
Why?
| Poverty | 2 | 2008 | 443 | 0.120 |
Why?
| Minority Groups | 1 | 2015 | 228 | 0.110 |
Why?
| Electronic Nicotine Delivery Systems | 1 | 2015 | 72 | 0.110 |
Why?
| Tobacco Smoke Pollution | 4 | 2015 | 217 | 0.110 |
Why?
| Patient Compliance | 2 | 2008 | 524 | 0.110 |
Why?
| Counseling | 3 | 2019 | 342 | 0.110 |
Why?
| Psychotropic Drugs | 1 | 1993 | 54 | 0.100 |
Why?
| Pregnancy Complications, Hematologic | 1 | 2012 | 16 | 0.100 |
Why?
| Pilot Projects | 3 | 2015 | 1375 | 0.100 |
Why?
| Southwestern United States | 2 | 2008 | 91 | 0.100 |
Why?
| Ambulatory Care | 1 | 2015 | 478 | 0.090 |
Why?
| Anemia | 1 | 2012 | 144 | 0.090 |
Why?
| Double-Blind Method | 3 | 2016 | 1664 | 0.090 |
Why?
| Practice Guidelines as Topic | 2 | 2016 | 1398 | 0.090 |
Why?
| International Cooperation | 1 | 2010 | 172 | 0.080 |
Why?
| Interpersonal Relations | 3 | 2010 | 339 | 0.080 |
Why?
| User-Computer Interface | 1 | 2010 | 143 | 0.080 |
Why?
| Maternal-Child Health Centers | 1 | 2008 | 9 | 0.080 |
Why?
| Education, Public Health Professional | 1 | 2008 | 6 | 0.080 |
Why?
| Delayed-Action Preparations | 2 | 2007 | 159 | 0.080 |
Why?
| Dose-Response Relationship, Drug | 2 | 2016 | 1857 | 0.080 |
Why?
| Telemedicine | 1 | 2016 | 665 | 0.080 |
Why?
| Reproducibility of Results | 1 | 2015 | 2799 | 0.080 |
Why?
| Body Mass Index | 1 | 2016 | 1967 | 0.080 |
Why?
| Diabetes Complications | 1 | 2010 | 212 | 0.080 |
Why?
| Drug Administration Routes | 1 | 2008 | 40 | 0.080 |
Why?
| Ambulatory Care Facilities | 1 | 2010 | 211 | 0.080 |
Why?
| Substance Abuse Treatment Centers | 1 | 2008 | 42 | 0.070 |
Why?
| Education, Medical | 1 | 2010 | 221 | 0.070 |
Why?
| Milk, Human | 1 | 2008 | 128 | 0.070 |
Why?
| Home Care Services | 1 | 2010 | 222 | 0.070 |
Why?
| Data Collection | 1 | 2010 | 623 | 0.070 |
Why?
| Social Class | 1 | 2008 | 205 | 0.070 |
Why?
| California | 1 | 2008 | 364 | 0.070 |
Why?
| Systems Theory | 1 | 2006 | 5 | 0.070 |
Why?
| Ganglionic Stimulants | 1 | 2006 | 10 | 0.070 |
Why?
| India | 3 | 2015 | 135 | 0.070 |
Why?
| Alcoholism | 1 | 1993 | 716 | 0.070 |
Why?
| Universities | 1 | 2008 | 339 | 0.070 |
Why?
| Women's Health | 1 | 2008 | 271 | 0.070 |
Why?
| Cooperative Behavior | 1 | 2008 | 383 | 0.070 |
Why?
| Internet | 1 | 2010 | 600 | 0.060 |
Why?
| Problem Solving | 1 | 2006 | 141 | 0.060 |
Why?
| Pediatrics | 2 | 2010 | 981 | 0.060 |
Why?
| Child Behavior | 1 | 2006 | 219 | 0.060 |
Why?
| Weight Loss | 1 | 2008 | 641 | 0.060 |
Why?
| Nonprescription Drugs | 1 | 2004 | 68 | 0.060 |
Why?
| Feces | 2 | 2012 | 373 | 0.050 |
Why?
| Socioeconomic Factors | 3 | 2014 | 1081 | 0.050 |
Why?
| Pregnancy | 3 | 2012 | 5520 | 0.050 |
Why?
| Attitude to Health | 1 | 2006 | 405 | 0.050 |
Why?
| Adaptation, Psychological | 1 | 2006 | 547 | 0.050 |
Why?
| Adolescent Behavior | 1 | 2006 | 488 | 0.050 |
Why?
| Global Health | 3 | 2010 | 288 | 0.050 |
Why?
| Administration, Oral | 1 | 2003 | 730 | 0.050 |
Why?
| Prevalence | 3 | 2017 | 2255 | 0.040 |
Why?
| Attitude of Health Personnel | 1 | 2007 | 976 | 0.040 |
Why?
| False Negative Reactions | 1 | 1999 | 50 | 0.040 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 1999 | 38 | 0.040 |
Why?
| Child | 2 | 2015 | 18407 | 0.040 |
Why?
| Encephalitozoon | 1 | 1998 | 2 | 0.040 |
Why?
| Encephalitozoonosis | 1 | 1998 | 2 | 0.040 |
Why?
| Time Factors | 1 | 2008 | 6141 | 0.040 |
Why?
| Observer Variation | 1 | 1999 | 298 | 0.040 |
Why?
| Parents | 1 | 2005 | 1190 | 0.040 |
Why?
| Prospective Studies | 1 | 2007 | 6232 | 0.030 |
Why?
| Health Status | 2 | 2012 | 722 | 0.030 |
Why?
| Cardiovascular Diseases | 1 | 2007 | 1729 | 0.030 |
Why?
| Placebos | 1 | 2016 | 198 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2003 | 2551 | 0.030 |
Why?
| Dopamine Uptake Inhibitors | 1 | 2015 | 54 | 0.030 |
Why?
| Education, Nonprofessional | 1 | 2015 | 8 | 0.030 |
Why?
| Models, Educational | 1 | 2015 | 85 | 0.030 |
Why?
| Lung Neoplasms | 1 | 2007 | 2201 | 0.030 |
Why?
| Administration, Inhalation | 2 | 2006 | 641 | 0.030 |
Why?
| Child of Impaired Parents | 1 | 1993 | 40 | 0.030 |
Why?
| Patient Satisfaction | 1 | 2016 | 580 | 0.030 |
Why?
| Hookworm Infections | 1 | 2012 | 3 | 0.030 |
Why?
| Nepal | 1 | 2012 | 20 | 0.030 |
Why?
| Body Weights and Measures | 1 | 2012 | 33 | 0.030 |
Why?
| Pregnancy Complications, Parasitic | 1 | 2012 | 9 | 0.030 |
Why?
| Overweight | 1 | 2016 | 474 | 0.020 |
Why?
| Primary Health Care | 2 | 2015 | 1512 | 0.020 |
Why?
| Anemia, Iron-Deficiency | 1 | 2012 | 54 | 0.020 |
Why?
| Social Environment | 1 | 1993 | 284 | 0.020 |
Why?
| Rural Population | 2 | 2008 | 446 | 0.020 |
Why?
| Community-Institutional Relations | 1 | 2010 | 89 | 0.020 |
Why?
| Cultural Competency | 1 | 2010 | 72 | 0.020 |
Why?
| Mass Media | 1 | 2010 | 37 | 0.020 |
Why?
| Risk Factors | 2 | 2012 | 8642 | 0.020 |
Why?
| Pediatric Obesity | 1 | 2016 | 492 | 0.020 |
Why?
| Northwestern United States | 1 | 2008 | 53 | 0.020 |
Why?
| Patient Care Team | 1 | 1993 | 515 | 0.020 |
Why?
| Anthropology, Cultural | 1 | 2006 | 16 | 0.020 |
Why?
| Harm Reduction | 1 | 2006 | 24 | 0.020 |
Why?
| Societies, Scientific | 1 | 2006 | 47 | 0.020 |
Why?
| Family | 1 | 2010 | 591 | 0.020 |
Why?
| Carbon Monoxide | 1 | 2006 | 65 | 0.020 |
Why?
| Morals | 1 | 2006 | 65 | 0.020 |
Why?
| Research Support as Topic | 1 | 2006 | 108 | 0.020 |
Why?
| Students, Nursing | 1 | 2006 | 58 | 0.020 |
Why?
| Diet | 1 | 2012 | 1076 | 0.020 |
Why?
| Physician's Role | 1 | 2006 | 199 | 0.010 |
Why?
| Health Planning Guidelines | 1 | 2003 | 25 | 0.010 |
Why?
| Physician-Patient Relations | 1 | 2007 | 463 | 0.010 |
Why?
| Public Health | 1 | 2006 | 435 | 0.010 |
Why?
| Sex Factors | 1 | 2007 | 1721 | 0.010 |
Why?
| Students, Medical | 1 | 2006 | 272 | 0.010 |
Why?
| Physicians, Family | 1 | 2003 | 201 | 0.010 |
Why?
| Physicians | 1 | 2007 | 772 | 0.010 |
Why?
| Administration, Cutaneous | 1 | 1999 | 117 | 0.010 |
Why?
| Clinical Trials as Topic | 1 | 2003 | 937 | 0.010 |
Why?
| Water Supply | 1 | 1998 | 70 | 0.010 |
Why?
| Mexico | 1 | 1998 | 162 | 0.010 |
Why?
| Fluorescent Antibody Technique | 1 | 1998 | 396 | 0.010 |
Why?
| Drug Therapy, Combination | 1 | 1999 | 955 | 0.010 |
Why?
| Weight Gain | 1 | 1999 | 451 | 0.010 |
Why?
| Quality of Life | 1 | 2006 | 2359 | 0.010 |
Why?
| Child, Preschool | 1 | 2008 | 9093 | 0.010 |
Why?
| Treatment Outcome | 1 | 2006 | 9122 | 0.010 |
Why?
| Antibodies, Monoclonal | 1 | 1998 | 1268 | 0.010 |
Why?
| Animals | 1 | 1998 | 31867 | 0.000 |
Why?
|
|
Muramoto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|